Skip to content

Ikram Slimani

3 papers in the library · publishing 2024-2026

Papers

Sort Most recent Most cited

Insight into cannabis use disorder in people with psychotic disorders

BJPsych Open August 25, 2026 Edward Chesney, Millie Lloyd, Sébastien Brodeur et al.

BACKGROUND: Cannabis use is common in people with psychosis and is associated with poor outcomes. AIMS: To assess insight into cannabis use disorder, perceptions about how cannabis use influences mental health and the desire to change cannabis use among people with psychotic disorders. METHOD: Adults with a psychotic disorder and comorbid cannabis use disorder were asked about the impact of...

Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.

Neuropsychopharmacology November 2025 Edward Chesney, Dominic Oliver, Ananya Sarma et al.

In patients with schizophrenia, cannabis use exacerbates symptoms and can lead to a relapse of psychosis. Some experimental studies in healthy volunteers suggest that pre-treatment with cannabidiol (CBD) may reduce these effects, but others do not. Here, we investigated whether pre-treatment with CBD ameliorates the acute adverse effects of cannabis in patients with schizophrenia. Participants...

Psychosis associated with cannabis withdrawal: systematic review and case series

The British Journal of Psychiatry December 3, 2024 Edward Chesney, Thomas J. Reilly, Fraser Scott et al.

Background Abrupt cessation of heavy cannabis use can cause a withdrawal syndrome characterised by irritability, anxiety, insomnia, reduced appetite and restlessness. Recent reports have also described people in whom cannabis withdrawal immediately preceded the acute onset of psychosis. Aims To identify cases of psychosis associated with cannabis withdrawal. Method We completed a systematic...